Stay updated with breaking news from Fugene Genetics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous09.01.2024 / 14:01 CET/CESTThe issuer is solely responsible for the content of this announcement.Mainz Biomed Provides Year-End Corporate Review 2023 European Study ColoFuture and U.S. Study eAArly DETECT report sensitivity and specificity for the detection of Co...
Mainz Biomed Provides Year-End Corporate Review 2023...
ColoAlert® Revenue Increases 102% Year Over Year for the Nine Months Ended September 30, 2023ColoFuture Study Reported Groundbreaking Results Demonstrating Sensitivity for Colorectal Cancer of 94%...
18.07.2023 - Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous Mainz Biomed Announces Collaboration with Fugene Genetics in Israel 18.07.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed Announces ... Seite 1